Cancer Rop Co. Ltd. Capital Reinvestment Ratio
Cancer Rop Co. Ltd. capital reinvestment ratio. Cancer Rop Co. Ltd. (180400) has a Capital Reinvestment Ratio of 2.01x as of December 2022, meaning it reinvests 2% of its operating cash flow (₩865.55 Million) in capital expenditures (₩1.74 Billion). See Cancer Rop Co. Ltd. (180400) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cancer Rop Co. Ltd. (2014–2022)
Capital reinvestment ratio of Cancer Rop Co. Ltd. from 2014 to 2022. This chart tracks Cancer Rop Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods. See 180400 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cancer Rop Co. Ltd. Capital Reinvestment Ratio by Year (2014–2022)
Cancer Rop Co. Ltd. capital reinvestment ratio by year from 2014 to 2022. For the full cash flow conversion analysis, see how efficiently does Cancer Rop Co. Ltd. generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.01x | ₩865.55 Million | ₩1.74 Billion | ▲ +397.1% |
| 2014 | 0.40x | ₩783.83 Million | ₩316.72 Million | — |